Lysosomal lipidomics identifies glycosylated bis(monoacylglycero)phosphate as a novel biomarker of mutant GBA1
Mutations in GBA1, which encodes the lysosomal enzyme glucocerebrosidase (GCase), cause Gaucher disease (GD) and represent a major genetic risk factor for